PerioTrap has published its efficient targeted periodontitis strategy that could minimize side effects and the overuse of broad-spectrum antibiotics.

PerioTrap has published its efficient targeted periodontitis strategy that could minimize side effects and the overuse of broad-spectrum antibiotics. It was developed and tested together with…


PerioTrap Pharmaceuticals ist Gesamtsieger des IQ Innovationspreis

Für die Kombination aus einem neuartigen Medikament und Therapieansatz zur Bekämpfung von Paradontitis auslösenden Keimen im Mundraum wurde die PerioTrap Pharmaceuticals GmbH aus Halle (Saale) mit…


Antimicrobial activity study has been published

After our mutual antimicrobial activity study has been published in April this year showing biofilm inhibition of our developed drug formulation, now the according paper detailing its optimized…